Dudediligence.

Vir Biotechnology, Inc

VIRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$2.4MSep ’24$12.4MDec ’24$3.0MMar ’25$1.2MJun ’25$240,000Sep ’25$64.1MDec ’25−$29,000Mar ’26$238.9MJun ’26
Net income, by quarter
−$213.7MSep ’24−$104.6MDec ’24−$121.0MMar ’25−$111.0MJun ’25−$163.1MSep ’25−$42.9MDec ’25−$125.7MMar ’26$80.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$1.10B$1.62B$86.2M$74.2M$68.6M
Gross profit$1.03B$1.47B$83.4M$73.4M$68.5M
Operating income$420.8M$833.1M−$684.3M−$587.2M−$479.3M
Net income$528.6M$515.8M−$615.1M−$522.0M−$438.0M
Operating cash flow−$47.6M$1.66B−$778.8M−$446.4M−$391.8M
Free cash flow−$69.4M$1.60B−$800.4M−$453.7M−$396.6M
Cash$347.8M$848.6M$241.6M$222.9M$232.2M
Shares outstanding131.2M133.2M134.8M137.0M139.5M